Featured Research

from universities, journals, and other organizations

Scientists report success growing cartilage to reconstruct nostrils and implanting tissue-engineered vaginal organs into humans

Date:
April 10, 2014
Source:
The Lancet
Summary:
Two new articles report the first ever successful operations in humans to reconstruct the alar wings of the nose (nostrils), and to implant tissue-engineered vaginal organs in women with a rare syndrome that causes the vagina to be underdeveloped or absent, in both cases using the patients’ own tissue.

Engineering a vaginal organ: The scaffold is made of a biodegradable material.
Credit: Wake Forest Institute for Regenerative Medicine

Two new articles published in The Lancet report the first ever successful operations in humans to reconstruct the alar wings of the nose (nostrils) (Martin et al), and to implant tissue-engineered vaginal organs in women with a rare syndrome that causes the vagina to be underdeveloped or absent (Atala et al), in both cases using the patients' own tissue.

In one paper, led by Professor Ivan Martin from the University of Basel in Switzerland, scientists report having engineered a human cartilage graft from patients' own nasal septum cartilage cells to successfully rebuild the nostrils (alar lobule) of five individuals whose noses were damaged by skin cancer. One year after reconstruction, all five recipients were satisfied with their ability to breathe, as well as the cosmetic appearance of their nose, and did not report any local or systemic adverse events.

The nose is the most common site of non-melanoma skin cancer, because of its cumulative exposure to sunlight, with the highest frequency of cancer occurring on the alar lobule. Currently, when removing skin cancers, surgeons often have to cut away parts of cartilage, (for instance from the nasal septum, ear, or rib) as grafts to functionally reconstruct the tumour excision site. However, this painful and invasive procedure involves major additional surgery, and has been associated with complications at the site from which cartilage has been removed.

A team from the University of Basel, Switzerland, investigated an alternative approach using engineered cartilage tissue grown from patients' own cells. They extracted the cartilage cells (chondrocytes) from the nasal septum of each patient, and multiplied the cells by exposing them to growth factors for two weeks. The expanded cells were seeded onto collagen membranes and cultured for two additional weeks, generating cartilage 40 times larger than the original biopsy. When the engineered grafts were ready they were shaped according to the defect and implanted.

According to Professor Martin, "The engineered cartilage had clinical results comparable to the gold standard cartilage graft surgery. This new technique could help the body accept the new tissue more easily, and improve the stability and functionality of the nostril. Our success is based on the long-standing, effective integration in Basel between our experimental group at the Department of Biomedicine and the surgical disciplines. It opens the way to using this engineered cartilage for more challenging reconstructions in facial surgery such as the complete nose, eyelid, or ear. The same engineered grafts are currently being tested in a parallel study for articular cartilage repair in the knee. Despite this optimism, the use of these procedures in the routine clinical practice is still rather distant, as it requires rigorous assessment of efficacy on larger cohorts of patients, and the development of business models and manufacturing paradigms that will guarantee cost-effectiveness."

In another Article, a team of scientists in the US and Mexico, led by Professor Anthony Atala from Wake Forest School of Medicine, USA, report on the long-term success of tissue-engineered vaginal organs implanted in four women, aged 13-18 years, with a condition known as Mayer-Rokitansky-Küster-Hauser syndrome that causes the vagina to be underdeveloped or absent. Eight years after transplantation, the organs continue to function as if they were native tissue and all recipients are sexually active, report no pain, and are satisfied with their desire/arousal, lubrication, and orgasm.

The team obtained a vulvar tissue biopsy from each patient from which they grew smooth muscle cells and vaginal epithelial cells in the lab. The cells were then placed onto specially designed vagina-shaped biodegradeable scaffolds and left to grow for 7 days. The researchers then surgically implanted the engineered vaginas, which remain structurally and functionally normal 8 years on.

According to Professor Atala, "Yearly tissue biopsy samples show that the reconstructed tissue is histologically and functionally similar to normal vaginal tissue. This technique is a viable option for vaginal reconstruction and has several advantages over current reconstructive methods because only a small biopsy of tissue is required, and using vaginal cells may reduce complications that arise from using non-vaginal tissue (eg, segments of large intestine or skin) such as infection and graft shrinkage."

According to Professor Martin Birchall, of UCL Ear Institute, London, UK, author of a Comment linked to both studies, "These authors have not only successfully treated several patients with a difficult clinical problem, but addressed some of the most important questions facing translation of tissue engineering technologies. The steps between first-in-human experiences such as those reported here and their use in routine clinical care remain many, including larger trials with long-term follow-up, the development of clinical grade processing, scale-out, and commercialisation. However, these hurdles are common to all potentially disruptive technologies, and many countries now have large translational income streams, engaged biotech companies and streamlined regulatory processes that may reduce the time to routine use significantly."


Story Source:

The above story is based on materials provided by The Lancet. Note: Materials may be edited for content and length.


Journal References:

  1. Ilario Fulco, Sylvie Miot, Martin D Haug, Andrea Barbero, Anke Wixmerten, Sandra Feliciano, Francine Wolf, Gernot Jundt, Anna Marsano, Jian Farhadi, Michael Heberer, Marcel Jakob, Dirk J Schaefer, Ivan Martin. Engineered autologous cartilage tissue for nasal reconstruction after tumour resection: an observational first-in-human trial. The Lancet, 2014; DOI: 10.1016/S0140-6736(14)60544-4
  2. Atlántida M Raya-Rivera, Diego Esquiliano, Reyna Fierro-Pastrana, Esther López-Bayghen, Pedro Valencia, Ricardo Ordorica-Flores, Shay Soker, James J Yoo, Anthony Atala. Tissue-engineered autologous vaginal organs in patients: a pilot cohort study. The Lancet, 2014; DOI: 10.1016/S0140-6736(14)60542-0

Cite This Page:

The Lancet. "Scientists report success growing cartilage to reconstruct nostrils and implanting tissue-engineered vaginal organs into humans." ScienceDaily. ScienceDaily, 10 April 2014. <www.sciencedaily.com/releases/2014/04/140410194352.htm>.
The Lancet. (2014, April 10). Scientists report success growing cartilage to reconstruct nostrils and implanting tissue-engineered vaginal organs into humans. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2014/04/140410194352.htm
The Lancet. "Scientists report success growing cartilage to reconstruct nostrils and implanting tissue-engineered vaginal organs into humans." ScienceDaily. www.sciencedaily.com/releases/2014/04/140410194352.htm (accessed July 23, 2014).

Share This




More Plants & Animals News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Stone Fruit Listeria Scare Causes Sweeping Recall

Stone Fruit Listeria Scare Causes Sweeping Recall

Newsy (July 22, 2014) — The Wawona Packing Company has issued a voluntary recall on the stone fruit it distributes due to a possible Listeria outbreak. Video provided by Newsy
Powered by NewsLook.com
Michigan Plant's Goal: Flower and Die

Michigan Plant's Goal: Flower and Die

AP (July 22, 2014) — An 80-year-old agave plant, which is blooming for the first and only time at a University of Michigan conservatory, will die when it's done (July 22) Video provided by AP
Powered by NewsLook.com
Huge Schizophrenia Study Finds Dozens Of New Genetic Causes

Huge Schizophrenia Study Finds Dozens Of New Genetic Causes

Newsy (July 22, 2014) — The 83 new genetic markers could open dozens of new avenues for schizophrenia treatment research. Video provided by Newsy
Powered by NewsLook.com
CDC Head Concerned About a Post-Antibiotic Era

CDC Head Concerned About a Post-Antibiotic Era

AP (July 22, 2014) — Sounding alarms about the growing threat of antibiotic resistance, CDC Director Tom Frieden warned Tuesday if the global community does not confront the problem soon, the world will be living in a devastating post-antibiotic era. (July 22) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins